{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:15:41Z","timestamp":1779347741812,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.leukres.2005.07.001","type":"journal-article","created":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T11:12:51Z","timestamp":1124190771000},"page":"211-221","source":"Crossref","is-referenced-by-count":4,"title":["IgH and TCR\u03b3 gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias"],"prefix":"10.1016","volume":"30","author":[{"given":"M.","family":"Golemovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Su\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zadro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mrsi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mikuli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Labar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.j.","family":"Raji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Batini\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2005.07.001_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01714978","article-title":"A classification of acute leukemia for the","volume":"62","author":"Catovsky","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2005.07.001_bib2","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterisation of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.2003.04715.x","article-title":"Adult T-biphenotypic acute leukemia: clinical and biological features and outcome","volume":"123","author":"Rubio","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.07.001_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.20163","article-title":"Acute lymphoblastic leukemia with the phenotype of a putative B-cell\/T-cell bipotential precursor","volume":"77","author":"Lau","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2005.07.001_bib5","first-page":"64","article-title":"Definition of acute biphenotypic leukemia","volume":"82","author":"Matutes","year":"1997","journal-title":"Hematologica"},{"key":"10.1016\/j.leukres.2005.07.001_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cyto.a.10104","article-title":"Immunophenotyping of acute leukemias and myelodysplastic syndromes","volume":"58A","author":"Orfao","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2005.07.001_bib7","first-page":"699","article-title":"Outcome of biphenotypic acute leukemia","volume":"84","author":"Killick","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2005.07.001_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.1998.00523.x","article-title":"Adult biphenotypic acute leukemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression","volume":"100","author":"Legrand","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.07.001_bib9","first-page":"154","article-title":"Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping","volume":"86","author":"Wuchtier","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2005.07.001_bib10","first-page":"1283","article-title":"Cytogenetic findings in acute biphenotypic leukemia","volume":"10","author":"Carbonell","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib11","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/sj.leu.2401214","article-title":"The value of c-kit in the diagnosis of biphenotypic acute leukemia","volume":"12","year":"1998","journal-title":"Leukaemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib12","first-page":"83","article-title":"Imunoloska fenotipizacija akutnih leukemija djecje dobi","volume":"78","author":"Batinic","year":"1997","journal-title":"Pediatr Croat"},{"key":"10.1016\/j.leukres.2005.07.001_bib13","first-page":"877","article-title":"Consensus protocol for the flow cytometric immunophenotyping of haematopoietic malignancies","volume":"10","author":"Rothe","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib14","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1073\/pnas.86.13.5123","article-title":"Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementary-determining region (CDR-III)-specific probes","volume":"86","author":"Yamada","year":"1989","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.leukres.2005.07.001_bib15","first-page":"1459","article-title":"Monitoring of adult B-cell lineage acute lymphoblastic leukemia: validation of a simple method for detecting immunoglobulin heavy chain gene clonality","volume":"7","author":"Salo","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2141.1996.6372268.x","article-title":"Multiplex PCR for rapid detection of T-cell receptor-gamma chain gene rearrangements in patients with lymphoproliferative diseases","volume":"94","author":"F\u00f6dinger","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.07.001_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V78.1.192.192","article-title":"Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction","volume":"78","author":"Trainor","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood.V87.5.1737.1737","article-title":"Expression of HOX C4, HOX C5 and HOX C6in human lymphoid cell lines, leukemias and benign and malignant lymphoid tissue","volume":"87","author":"Oostveen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.leu.2401051","article-title":"Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation","volume":"12","author":"Kr\u00e4mer","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2401410","article-title":"Expression of HOX genes, HOX cofactors and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells","volume":"13","author":"Kawagoe","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib21","first-page":"2067","article-title":"Cyclin A1 expression in leukemia and normal hematopoietic cells","volume":"93","author":"Yang","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.leukres.2005.07.001_bib23","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood.V97.8.2286","article-title":"Overexpression of HOXA10perturbs human lymphomyelopoiesis in vitro and in vivo","volume":"97","author":"Buske","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib24","first-page":"919","article-title":"Lineage commitment in biphenotypic acute leukemia","volume":"7","author":"Buccheri","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V99.1.121","article-title":"Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion","volume":"99","author":"Thorsteindottir","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib26","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.V89.6.1922","article-title":"Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis","volume":"89","author":"Lawrence","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib27","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1080\/1042819031000119299","article-title":"Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia","volume":"44","author":"Casas","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2005.07.001_bib28","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1038\/sj.leu.2403178","article-title":"B-cell development in the presence of the MLL\/AF4 oncoprotein proceeds in the absence of HOXA7 and HOXA9 expression","volume":"17","author":"Bertrand","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2005.07.001_bib29","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.cub.2004.11.012","article-title":"An Mll-dependent Hox program drives hematopoietic progenitor expansion","volume":"14","author":"Ernst","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.leukres.2005.07.001_bib30","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1182\/blood.V96.12.3894","article-title":"The aberrant fusion proteins PML-RAR\u03b1 and PLZF-RAR\u03b1 contribute to the overexpression of cyclin A1 in acute promyleocytic leukemia","volume":"96","author":"M\u00fcller","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib31","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1073\/pnas.121540098","article-title":"Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1","volume":"98","author":"Liao","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.leukres.2005.07.001_bib32","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood.V94.12.4255","article-title":"C-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression","volume":"94","author":"M\u00fcller","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.07.001_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0145-2126(01)00131-X","article-title":"A novel predictive model of outcome in de novo AML based on S-phase activity and proliferative response of blast cells to haemopoietic growth factors","volume":"26","author":"Smith","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2005.07.001_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0145-2126(99)00125-3","article-title":"Kinetic characteristics of de novo and secondary AML cells influence their response to haemopoietic growth factor (HGF) priming and correlate with clinical outcome","volume":"23","author":"Smith","year":"1999","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2005.07.001_bib35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM199303043280904","article-title":"Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia","volume":"328","author":"L\u00f6wenberg","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260500278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260500278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T01:47:56Z","timestamp":1586396876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521260500278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S014521260500278X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2005.07.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}